Physician

Aki Morikawa, MD

According to 2025 Medicare claims, Aki Morikawa, MD (NPI: 1659539179) practices medical oncology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF MICHIGAN (NPI: 1609192020; TIN: 386006309) and primary practice location at 48109-5000. Morikawa is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Morikawa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 85 traditional Medicare patients, billed 254 HCPCS/CPT codes, and received $16,575 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 210 prescription claims across 72 beneficiaries totaling $426,257 in drug costs, led by Anastrozole (Anastrozole). Open Payments data shows 9 records totaling $37,476. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $14,039 and ending at $16,575. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $49,327 to $426,257. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	68	164	$14,039
2016	80	342	$37,709
2017	105	687	$90,651
2018	105	644	$88,727
2019	130	705	$91,909
2020	66	133	$8,989
2021	42	121	$10,522
2022	60	148	$14,038
2023	69	167	$13,229
2024	85	254	$16,575

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	31	85	$49,327
2016	40	156	$60,184
2017	46	141	$35,157
2018	68	172	$142,469
2019	76	224	$265,488
2020	86	287	$256,280
2021	75	212	$277,771
2022	57	171	$246,036
2023	67	190	$270,949
2024	72	210	$426,257

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	18	19	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	19	38	$76
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	18	18	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	31	47	$49
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	17	26	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Anastrozole	Anastrozole	93	7,457	$3,358
Letrozole	Letrozole	18	1,500	$2,079
Tamoxifen Citrate	Tamoxifen Citrate	14	896	$381

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	9	$37,476	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aki Morikawa, MD?

Tedicare shows public-source Medicare data for Aki Morikawa, MD (NPI 1659539179), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aki Morikawa, MD have ACO affiliation data?

Aki Morikawa, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Aki Morikawa, MD?

Aki Morikawa, MD is linked to REGENTS OF THE UNIVERSITY OF MICHIGAN (billing NPI 1609192020) in the available physician profile data.

Does Aki Morikawa, MD have Open Payments data?

Aki Morikawa, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.